8-K Announcements
6Feb 20, 2026·SEC
Feb 12, 2026·SEC
Feb 10, 2026·SEC
RXO, Inc. (RXO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
RXO, Inc. (RXO) stock price & volume — 10-year historical chart
RXO, Inc. (RXO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
RXO, Inc. (RXO) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 6, 2026 | $0.07vs $0.04-75.0% | $1.5Bvs $1.5B-1.4% |
| Q4 2025 | Nov 6, 2025 | $0.01vs $0.03-66.7% | $1.4Bvs $1.5B-6.2% |
| Q3 2025 | Aug 7, 2025 | $0.04vs $0.02+100.0% | $1.4Bvs $1.4B-2.0% |
| Q2 2025 | May 7, 2025 | $0.03vs $0.02-50.0% | $1.4Bvs $1.5B-7.3% |
RXO, Inc. (RXO) competitors in Freight Brokerage and 3PL Logistics — business model, growth, and fundamentals comparison
RXO, Inc. (RXO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RXO, Inc. (RXO) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Sales/Revenue | 3.36B | 4.69B | 4.8B | 3.93B | 4.55B | 5.74B |
| Revenue Growth % | - | 39.68% | 2.28% | -18.12% | 15.86% | 26.2% |
| Cost of Goods Sold | 2.82B | 3.95B | 3.94B | 3.2B | 3.77B | 4.73B |
| COGS % of Revenue | 83.94% | 84.33% | 82.07% | 81.54% | 82.79% | 82.32% |
| Gross Profit | 539M▲ 0% | 735M▲ 36.4% | 860M▲ 17.0% | 725M▼ 15.7% | 783M▲ 8.0% | 1.01B▲ 29.6% |
| Gross Margin % | 16.06% | 15.68% | 17.93% | 18.46% | 17.21% | 17.68% |
| Gross Profit Growth % | - | 36.36% | 17.01% | -15.7% | 8% | 29.63% |
| Operating Expenses | 479M | 543M | 737M | 686M | 839M | 1.02B |
| OpEx % of Revenue | 14.27% | 11.58% | 15.37% | 17.47% | 18.44% | 17.8% |
| Selling, General & Admin | 455M | 539M | 640M | 0 | 0 | 832K |
| SG&A % of Revenue | 13.55% | 11.49% | 13.34% | - | - | 0.01% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 24M | 4M | 97M | 686M | 839M | 1.02B |
| Operating Income | 60M▲ 0% | 192M▲ 220.0% | 123M▼ 35.9% | 39M▼ 68.3% | -56M▼ 243.6% | -7M▲ 87.5% |
| Operating Margin % | 1.79% | 4.09% | 2.56% | 0.99% | -1.23% | -0.12% |
| Operating Income Growth % | - | 220% | -35.94% | -68.29% | -243.59% | 87.5% |
| EBITDA | 136M | 273M | 209M | 106M | 31M | 109M |
| EBITDA Margin % | 4.05% | 5.82% | 4.36% | 2.7% | 0.68% | 1.9% |
| EBITDA Growth % | - | 100.74% | -23.44% | -49.28% | -70.75% | 251.61% |
| D&A (Non-Cash Add-back) | 76M | 81M | 86M | 67M | 87M | 116M |
| EBIT | 57M | 191M | 123M | 67M | 30M | -7M |
| Net Interest Income | 0 | 0 | -4M | -32M | -30M | -35M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 4M | 32M | 30M | 35M |
| Other Income/Expense | -3M | -1M | -4M | -35M | -248M | -108M |
| Pretax Income | 57M▲ 0% | 191M▲ 235.1% | 119M▼ 37.7% | 4M▼ 96.6% | -304M▼ 7700.0% | -115M▲ 62.2% |
| Pretax Margin % | 1.7% | 4.07% | 2.48% | 0.1% | -6.68% | -2% |
| Income Tax | 14M | 41M | 27M | 0 | -14M | -15M |
| Effective Tax Rate % | 24.56% | 21.47% | 22.69% | 0% | 4.61% | 13.04% |
| Net Income | 43M▲ 0% | 150M▲ 248.8% | 92M▼ 38.7% | 4M▼ 95.7% | -290M▼ 7350.0% | -100M▲ 65.5% |
| Net Margin % | 1.28% | 3.2% | 1.92% | 0.1% | -6.37% | -1.74% |
| Net Income Growth % | - | 248.84% | -38.67% | -95.65% | -7350% | 65.52% |
| Net Income (Continuing) | 43M | 150M | 92M | 4M | -290M | -100M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.37▲ 0% | 1.30▲ 251.4% | 0.79▼ 39.2% | 0.03▼ 95.8% | -2.17▼ 6577.6% | -0.59▲ 72.8% |
| EPS Growth % | - | 251.35% | -39.23% | -95.76% | -6577.61% | 72.81% |
| EPS (Basic) | 0.37 | 1.30 | 0.79 | 0.03 | -2.17 | -0.59 |
| Diluted Shares Outstanding | 116.4M | 116.4M | 116.4M | 119.46M | 133.41M | 168.46M |
| Basic Shares Outstanding | 116.4M | 116.4M | 116.4M | 116.87M | 133.41M | 168.46M |
| Dividend Payout Ratio | - | - | - | - | - | - |
RXO, Inc. (RXO) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Total Current Assets | 862M | 1.08B | 1.03B | 796M | 1.34B | 1.32B |
| Cash & Short-Term Investments | 70M | 29M | 98M | 5M | 35M | 18M |
| Cash Only | 70M | 29M | 98M | 5M | 35M | 18M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 772M | 1.01B | 900M | 743M | 1.23B | 1.25B |
| Days Sales Outstanding | 83.94 | 78.62 | 68.49 | 69.06 | 98.43 | 79.59 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 20M | 44M | 31M | 48M | 77M | 15M |
| Total Non-Current Assets | 1.01B | 985M | 1B | 1.03B | 2.08B | 1.96B |
| Property, Plant & Equipment | 236M | 239M | 278M | 319M | 411M | 372M |
| Fixed Asset Turnover | 14.22x | 19.62x | 17.25x | 12.31x | 11.07x | 15.44x |
| Goodwill | 630M | 630M | 630M | 630M | 1.12B | 1.11B |
| Intangible Assets | 124M | 100M | 79M | 68M | 499M | 453M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 18M | 16M | 15M | 12M | 42M | 18M |
| Total Assets | 1.87B▲ 0% | 2.07B▲ 10.6% | 2.03B▼ 1.8% | 1.82B▼ 10.1% | 3.41B▲ 87.1% | 3.28B▼ 4.0% |
| Asset Turnover | 1.80x | 2.27x | 2.36x | 2.15x | 1.33x | 1.75x |
| Asset Growth % | - | 10.59% | -1.79% | -10.14% | 87.07% | -4.01% |
| Total Current Liabilities | 629M | 816M | 823M | 682M | 1.06B | 1.04B |
| Accounts Payable | 390M | 520M | 501M | 414M | 568M | 539M |
| Days Payables Outstanding | 50.51 | 48 | 46.46 | 47.19 | 55.04 | 41.62 |
| Short-Term Debt | 0 | 0 | 4M | 3M | 17M | 92M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5M | 6M | 14M | 13M | 26M | 347M |
| Current Ratio | 1.37x | 1.33x | 1.25x | 1.17x | 1.26x | 1.27x |
| Quick Ratio | 1.37x | 1.33x | 1.25x | 1.17x | 1.26x | 1.27x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 173M | 182M | 621M | 549M | 737M | 698M |
| Long-Term Debt | 0 | 93M | 451M | 352M | 351M | 577M |
| Capital Lease Obligations | 86M | 93M | 114M | 150M | 215M | 192M |
| Deferred Tax Liabilities | 49M | 52M | 16M | 7M | 88M | 51M |
| Other Non-Current Liabilities | 38M | -56M | 40M | 40M | 83M | -122M |
| Total Liabilities | 802M | 998M | 1.44B | 1.23B | 1.8B | 1.74B |
| Total Debt | 116M | 228M | 617M | 558M | 664M | 861M |
| Net Debt | 46M | 199M | 519M | 553M | 629M | 843M |
| Debt / Equity | 0.11x | 0.21x | 1.05x | 0.94x | 0.41x | 0.56x |
| Debt / EBITDA | 0.85x | 0.84x | 2.95x | 5.26x | 21.42x | 7.90x |
| Net Debt / EBITDA | 0.34x | 0.73x | 2.48x | 5.22x | 20.29x | 7.73x |
| Interest Coverage | - | - | 30.75x | 2.09x | 1.00x | -0.20x |
| Total Equity | 1.07B▲ 0% | 1.07B▲ 0.2% | 587M▼ 45.1% | 594M▲ 1.2% | 1.61B▲ 171.4% | 1.54B▼ 4.4% |
| Equity Growth % | - | 0.19% | -45.14% | 1.19% | 171.38% | -4.4% |
| Book Value per Share | 9.18 | 9.19 | 5.04 | 4.97 | 12.08 | 9.15 |
| Total Shareholders' Equity | 1.07B | 1.07B | 587M | 594M | 1.61B | 1.54B |
| Common Stock | 0 | 1.07B | 1M | 1M | 2M | 2M |
| Retained Earnings | 0 | 0 | 2M | 6M | -284M | -384M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2M | -2M | -4M | -3M | -10M | -6M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
RXO, Inc. (RXO) cash flow — operating, investing & free cash flow history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|
| Cash from Operations | 25M | 155M | 310M | 89M | -12M | 51M |
| Operating CF Margin % | 0.74% | 3.31% | 6.46% | 2.27% | -0.26% | 0.89% |
| Operating CF Growth % | - | 520% | 100% | -71.29% | -113.48% | 525% |
| Net Income | 43M | 150M | 92M | 4M | -290M | -100M |
| Depreciation & Amortization | 76M | 81M | 86M | 67M | 87M | 116M |
| Stock-Based Compensation | 8M | 8M | 32M | 19M | 23M | 0 |
| Deferred Taxes | -9M | 3M | -20M | -8M | -19M | -21M |
| Other Non-Cash Items | 14M | 3M | 6M | 9M | 236M | 56M |
| Working Capital Changes | -107M | -90M | 114M | -2M | -49M | 0 |
| Change in Receivables | -264M | -242M | 92M | 158M | -109M | -5M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 87M | 129M | -14M | -86M | -65M | -16M |
| Cash from Investing | -39M | -38M | -56M | -66M | -1.06B | -71M |
| Capital Expenditures | -47M | -39M | -57M | -64M | -45M | -59M |
| CapEx % of Revenue | 1.4% | 0.83% | 1.19% | 1.63% | 0.99% | 1.03% |
| Acquisitions | 0 | 0 | 0 | 0 | -1.02B | -8M |
| Investments | - | - | - | - | - | - |
| Other Investing | 8M | 1M | 1M | -2M | 0 | -4M |
| Cash from Financing | 32M | -158M | -183M | -117M | 1.11B | 1M |
| Debt Issued (Net) | 0 | 0 | 451M | -99M | 9M | 31M |
| Equity Issued (Net) | 0 | 0 | -3M | -2M | 1.13B | -1M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -3M | -2M | 0 | -1M |
| Other Financing | 32M | -158M | -631M | -16M | -26M | -29M |
| Net Change in Cash | 19M▲ 0% | -41M▼ 315.8% | 69M▲ 268.3% | -93M▼ 234.8% | 30M▲ 132.3% | -18M▼ 160.0% |
| Free Cash Flow | -22M▲ 0% | 116M▲ 627.3% | 253M▲ 118.1% | 25M▼ 90.1% | -57M▼ 328.0% | -8M▲ 86.0% |
| FCF Margin % | -0.66% | 2.47% | 5.28% | 0.64% | -1.25% | -0.14% |
| FCF Growth % | - | 627.27% | 118.1% | -90.12% | -328% | 85.96% |
| FCF per Share | -0.19 | 1.00 | 2.17 | 0.21 | -0.43 | -0.05 |
| FCF Conversion (FCF/Net Income) | 0.58x | 1.03x | 3.37x | 22.25x | 0.04x | -0.51x |
| Interest Paid | 0 | 0 | 0 | 0 | 27M | 0 |
| Taxes Paid | 2M | 5M | 3M | 27M | 4M | 0 |
RXO, Inc. (RXO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.03% | 14.03% | 11.1% | 0.68% | -26.29% | -6.34% |
| Return on Invested Capital (ROIC) | 4.04% | 12.09% | 7.77% | 2.6% | -2.48% | -0.23% |
| Gross Margin | 16.06% | 15.68% | 17.93% | 18.46% | 17.21% | 17.68% |
| Net Margin | 1.28% | 3.2% | 1.92% | 0.1% | -6.37% | -1.74% |
| Debt / Equity | 0.11x | 0.21x | 1.05x | 0.94x | 0.41x | 0.56x |
| Interest Coverage | - | - | 30.75x | 2.09x | 1.00x | -0.20x |
| FCF Conversion | 0.58x | 1.03x | 3.37x | 22.25x | 0.04x | -0.51x |
| Revenue Growth | - | 39.68% | 2.28% | -18.12% | 15.86% | 26.2% |
RXO, Inc. (RXO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 20, 2026·SEC
Feb 12, 2026·SEC
Feb 10, 2026·SEC
RXO, Inc. (RXO) stock FAQ — growth, dividends, profitability & financials explained
RXO, Inc. (RXO) reported $5.74B in revenue for fiscal year 2025. This represents a 71% increase from $3.36B in 2020.
RXO, Inc. (RXO) grew revenue by 26.2% over the past year. This is strong growth.
RXO, Inc. (RXO) reported a net loss of $100.0M for fiscal year 2025.
RXO, Inc. (RXO) has a return on equity (ROE) of -6.3%. Negative ROE indicates the company is unprofitable.
RXO, Inc. (RXO) had negative free cash flow of $8.0M in fiscal year 2025, likely due to heavy capital investments.
RXO, Inc. (RXO) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates